← Back to Analyst Consensus 
SPRO Buy
Spero Therapeutics, Inc.
Current Price —
Implied Upside —
Analysts 8
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 0 reiterations from 0 firms
Next Earnings
Nov 16, 2026 (21 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Sep 14, 2026 | HC Wainwright & Co. | maintain | Buy → Buy | — | 44% |
| Jan 30, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $5 | 44% |
| Dec 20, 2024 | Evercore ISI Group | downgrade | Outperform → In-Line | $5 | 58% |
| Dec 2, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $5 | 44% |
| Nov 18, 2024 | TD Cowen | downgrade | Buy → Hold | $0 | 54% |
| Nov 15, 2024 | Cantor Fitzgerald | reiterate | — → Overweight | $0 | 50% |
| Nov 4, 2024 | HC Wainwright & Co. | maintain | Buy → Buy | $5 | 44% |
| Oct 3, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $7 | 44% |
| Aug 6, 2024 | TD Cowen | upgrade | Hold → Buy | $0 | 54% |
| Aug 6, 2024 | Cantor Fitzgerald | reiterate | — → Overweight | $0 | 50% |
| Aug 6, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $7 | 44% |
| May 16, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $7 | 44% |
| Apr 4, 2024 | Cantor Fitzgerald | reiterate | — → Overweight | $0 | 50% |
| Mar 18, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $7 | 44% |
| Nov 14, 2023 | HC Wainwright & Co. | reiterate | Buy → Buy | $7 | 44% |
| Sep 5, 2023 | HC Wainwright & Co. | reiterate | Buy → Buy | $7 | 44% |
| Aug 14, 2023 | HC Wainwright & Co. | maintain | Buy → Buy | $7 | 44% |
| Aug 1, 2023 | HC Wainwright & Co. | reiterate | Buy → Buy | $6 | 44% |
| Jul 20, 2023 | HC Wainwright & Co. | reiterate | Buy → Buy | $6 | 44% |
| Apr 10, 2023 | HC Wainwright & Co. | reiterate | — → Buy | $6 | 44% |
| Sep 26, 2022 | HC Wainwright & Co. | maintain | — → Buy | $6 | 44% |
| Sep 23, 2022 | Evercore ISI Group | upgrade | In-Line → Outperform | $8 | 58% |
| Aug 15, 2022 | HC Wainwright & Co. | maintain | — → Buy | $7 | 44% |
| May 23, 2022 | HC Wainwright & Co. | maintain | — → Buy | $10 | 44% |
| May 20, 2022 | Berenberg | downgrade | Buy → Hold | $2 | 29% |
| May 17, 2022 | Cantor Fitzgerald | maintain | — → Overweight | $5 | 50% |
| May 4, 2022 | Cowen & Co. | downgrade | Outperform → Market Perform | $0 | — |
| May 4, 2022 | Evercore ISI Group | downgrade | Outperform → In-Line | $2 | 58% |
| Apr 18, 2022 | HC Wainwright & Co. | maintain | — → Buy | $37 | 44% |
| Mar 21, 2022 | HC Wainwright & Co. | maintain | — → Buy | $43 | 44% |
| Oct 1, 2021 | Oppenheimer | downgrade | Outperform → Perform | $0 | 52% |
| Jan 22, 2021 | HC Wainwright & Co. | maintain | — → Buy | $40 | 44% |
| Dec 16, 2020 | Berenberg | initiate | — → Buy | $47 | 29% |
| Nov 23, 2020 | HC Wainwright & Co. | maintain | — → Buy | $33 | 44% |
| Sep 29, 2020 | Evercore ISI Group | initiate | — → Outperform | $70 | 58% |
| May 11, 2020 | HC Wainwright & Co. | reiterate | — → Buy | $28 | 44% |
| Mar 17, 2020 | Stifel | maintain | — → Buy | $21 | 53% |
| Nov 5, 2019 | HC Wainwright & Co. | maintain | — → Buy | $35 | 44% |
| Sep 9, 2019 | Janney Montgomery Scott | initiate | — → Buy | $0 | 55% |
| Oct 16, 2018 | B of A Securities | downgrade | Neutral → Underperform | $9 | 53% |
| May 11, 2018 | HC Wainwright & Co. | initiate | — → Buy | $28 | 44% |
| Feb 9, 2018 | Cantor Fitzgerald | initiate | — → Overweight | $27 | 50% |
| Nov 27, 2017 | B of A Securities | initiate | — → Neutral | $16 | 53% |
| Nov 27, 2017 | Cowen & Co. | initiate | — → Outperform | $0 | — |
| Nov 27, 2017 | Stifel | initiate | — → Buy | $26 | 53% |
Price Target Trend
Jun 19, 2026 Oct 26, 2026
EPS Estimates
0q —
+1q —
0y —
+1y —
Cross-Platform Signals
No cross-platform signals in the last 90 days